Though autografts represent a prospective bone graft material option, monetizing their worth is complicated as autograft materials are not purchased. Instead, the autograft market is evaluated separately from the various alternatives that have a price attached to their worth. Though the xenograft market has traditionally been dominated by Geistlich, and continues to be, there has recently been an emergence of several local companies, providing inexpensive products than those offered by international brands. With inexpensive options available in a cost-sensitive country, the xenograft market is set to continuing growing over the forecast period. The total market is expected to grow primarily driven by the increasing number of dental implant treatments and an increasing acceptance of bone grafting.

The growth of the dental bone grafting market is very closely linked to the growth of the dental implant industry. Dental bone grafting procedures are typically associated with dental implants to restore the edentulous area of a missing tooth. Dental implants require sufficient bone tissue in the jawbone to support the implant and ensure proper integration into the mouth. If a patient has endured being toothless (edentulism) for a prolonged period, they run a high probability of having insufficient bone tissue. In this case, they ideally required a bone graft in order to maximize the outcome of a dental implant surgery. The bone grafting market is segmented on the basis of the material’s origins. Dental bone graft procedures include autografts, allografts, xenografts and synthetics.